Tofisopam (International)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N05BA23

CAS registry number (Chemical Abstracts Service)

0022345-47-7

Chemical Formula

C22-H26-N2-O4

Molecular Weight

382

Therapeutic Categories

Anxiolytic agent

Benzodiazepine derivative

Chemical Name

5H-2,3-Benzodiazepin, 1-(3,4-dimetoxyphenyl)-5-etyl-7,8-dimetoxy-4-metyl-

Foreign Names

• Tofisopamum (Latin)
• Tofisopam (German)
• Tofisopam (French)
• Tofisopam (Spanish)

Generic Names

• Tofisopam (OS: JAN, DCF)
• EGYT 341 (IS)
• Tofisopam (PH: JP XVII)

Brand Names

• Grandaxin
  Egis, Bulgaria; Egis, Georgia; Egis, Lithuania; Egis, Latvia; Egis, Serbia; Egis, Russian Federation; Egis, Slovakia; Egis Pharmaceuticals, Romania; Egis Praha, Czech Republic; Medimpex, Pakistan; Mochida Pharmaceutical, Japan; Searle, Egypt
• Grandaxin 10%
  Mochida Pharmaceutical, Japan
• Grandaxin 50 mg
  Egis, Hungary
• Granpam
  Towa Yakuhin, Japan
• Isotan
  Hanlim, South Korea
• No Deprine
  Alphamoun, Egypt
• Tofisopam
  Nichi-Iko Pharmaceutical, Japan; Nihon Generic, Japan; Sawai Seiyaku, Japan
• Tofisopam 10%
  Choseido Pharmaceutical, Japan; Tsuruhara Seiyaku Pharmaceutical, Japan

Glossary

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer